Dr Kathryn Alsop
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
97 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Real-world comparative outcomes of neoadjuvant chemotherapy with interval cytoreductive surgery versus primary cytoreductive surgery in epithelial ovarian cancer: insights from the australian ovarian cancer study (AOCS)
DOI: 10.1016/j.ijgc.2025.1030762025
Journal article
Understanding Contemporary Endometrial Cancer Survivorship Issues: Umbrella Review and Healthcare Professional Survey †
DOI: 10.3390/cancers171626962024
Journal article
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer
DOI: 10.1172/JCI1795012024
Journal article
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer
DOI: 10.1038/s41467-024-50137-y2024
Conference Proceedings
Development of an endometrial cancer survivorship checklist: Umbrella review and expert input
2021
Research grants (international)
Going to Extremes: Learning From Exceptional Responders to Improve Outcomes for Women With High-Grade Serous Ovarian Cancer.
2014
Journal article
Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts
DOI: 10.1016/j.molonc.2014.01.008
RECENT SCHOLARLY WORKS
2024
Journal article
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
DOI: 10.1158/1078-0432.CCR-23-35522024
Journal article
Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis
DOI: 10.1158/1055-9965.EPI-23-09842023
Journal article
Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer
DOI: 10.1038/s41598-023-48153-x2023
Journal article
Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.
DOI: 10.1101/2023.11.09.232983212023
Journal article
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme
DOI: 10.1111/his.14906